IA
UTMD icon

IFP Advisors’s Utah Medical Products UTMD Stock Holding History

IFP Advisors’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$897 Buy
13
+1
+8% +$66 ﹤0.01% 4529
2026
Q1 		$744 Sell
12
-1
-8% -$63 ﹤0.01% 4311
2025
Q4 		$727 Sell
13
-4
-24% -$232 ﹤0.01% 4173
2025
Q3 		$1.07K Buy
17
+7
+70% +$414 ﹤0.01% 3931
2025
Q2 		$569 Buy
+10
New +$544 ﹤0.01% 4401

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IFP Advisors's UTMD Position: Q2 2026 in Review

IFP Advisors increased its Utah Medical Products (UTMD) stake by 8.3% in Q2 2026, buying an estimated $66 and bringing the position to 13 shares worth $897. The position accounts for ﹤0.01% of the portfolio, ranked #4529.

IFP Advisors first reported a position in UTMD in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.07K in Q3 2025. 114 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • IFP Advisors held 13 shares of Utah Medical Products worth $897 as of Q2 2026.
  • IFP Advisors bought 1 Utah Medical Products share in Q2 2026, an estimated $66.
  • Utah Medical Products made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4529 holding.
  • IFP Advisors first reported a position in Utah Medical Products in Q2 2025 and has held it in 5 quarters since.
  • IFP Advisors's Utah Medical Products position peaked at $1.07K in Q3 2025.
  • 114 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.